RUMORED BUZZ ON ABBV-744 AS A POTENTIAL THERAPEUTIC OPTION FOR AGGRESSIVE CANCERS

In Section A, members will obtain distinct doses and schedules of oral ABBV-744 pill to identify safe dosing program. Added members are going to be enrolled within the determined monotherapy dosign regimen. In Section B, individuals will acquire oral ruxolitinib and ABBV-744 might be presented as "include-on" therapy. In Phase C, members will recei